Ciro Cordeiro

Ciro Cordeiro, PhD, is a Scientist III at Merck since April 2024, with prior experience as a Senior Scientist at Soos Technology from December 2021 to June 2023. At Soos Technology, Ciro Cordeiro developed SOPs for dissection of chicken embryos, optimized high-throughput assays using qPCR, and served as a liaison between Syracuse University and Soos Technology teams. Ciro's academic background includes a Postdoctoral Associate position at Cornell University, focusing on E3 Ubiquitin ligases and membrane protein traffic, and a Research Assistant role at the University of Georgia, where various research projects were undertaken. Ciro Cordeiro’s educational qualifications include a PhD in Cellular Biology from the University of Georgia, a Master's in Molecular Pathology from Universidade de Brasília, and a Bachelor's in Biology from the same institution.